|
|
|
Volumn 312, Issue 5775, 2006, Pages 827-
|
|
Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
ARTICLE;
BIOTECHNOLOGY;
DRUG ANTAGONISM;
DRUG INDUSTRY;
LEGAL ASPECT;
PATENT;
UNITED STATES;
BIOTECHNOLOGY;
DRUG INDUSTRY;
NF-KAPPA B;
PATENTS;
UNITED STATES;
|
|
EID: 33646833099
PISSN: None
EISSN: 10959203
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
